This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beyond Barriers Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas A. Degregoris and Antioxidant Dosage Forms for CNS Disorders.
Introduction
Thomas A. Degregoris is an inventor associated with Glencoe, Illinois. His patent work concerns sublingual and buccal dosage forms intended to support treatment of central nervous system disorders.
Latest Patents
Degregoris is associated with 1 patent, titled “Sublingual or Buccal Dosage Forms Comprising Antioxidants for Treatment of Central Nervous System Disorders.” The invention describes dosage forms containing at least one antioxidant, such as N-acetyl cysteine (NAC) or a pharmaceutically acceptable salt thereof. These forms are administered under the tongue or inside the cheek for treating CNS disorders, including traumatic brain injury and stroke.
Career Highlights
Degregoris is associated with Beyond Barriers Therapeutics, Inc. His patent reflects work on pharmaceutical delivery approaches that apply antioxidant compounds to potential treatments for neurological conditions.
Collaborations
Degregoris’s identified coworker is Ryan Kole. Their association provides a professional connection related to the company and its therapeutic research.
Conclusion
Thomas A. Degregoris’s patent focuses on antioxidant-containing sublingual and buccal formulations for CNS disorders, including traumatic brain injury and stroke.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile